Viread
New Data Support TAF Switch in HIV
A subanalysis of the phase 3 Study 109 supports switching HIV patients who are virologically suppressed from a ...
OCTOBER 18, 2017
FDA Approves Gilead’s Vemlidy To Treat Chronic HBV
Vemlidy is a once-daily treatment that demonstrated similar efficacy with improved renal and bone laboratory safety ...
NOVEMBER 18, 2016
Load more